American International Group, Inc. Merrimack Pharmaceuticals Inc Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 13, 2024	SELL	$13.06 - $15.0 $574 - $660	-44 Reduced 0.85%	5,160 $76,000
Q4 2023 Feb 13, 2024	SELL	$12.02 - $13.41 $252 - $281	-21 Reduced 0.4%	5,204 $69,000
Q3 2023 Nov 13, 2023	BUY	$11.6 - $12.52 $2,157 - $2,328	186 Added 3.69%	5,225 $64,000
Q2 2023 Aug 04, 2023	BUY	$12.02 - $13.07 $60,568 - $65,859	5,039 New	5,039 $61,000
Q2 2018 Aug 08, 2018	SELL	$3.86 - $7.61 $31,659 - $62,417	-8,202 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$6.24 - $9.15 $2,758 - $4,044	-442 Reduced 5.11%	8,202 $66,000
Q4 2017 Feb 09, 2018	BUY	$7.99 - $11.87 $343 - $510	43 Added 0.5%	8,644 $89,000
Q3 2017 Nov 09, 2017	BUY	$9.13 - $11.72 $78,527 - $100,803	8,601	8,601 $125,000

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.